ICMR & Panacea Biotec complete enrollment for India's first indigenous dengue vaccine phase 3 study
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
Test delivers results in just 18 minutes, enabling faster laboratory workflows and patient management during outbreaks
The Dengue IgG/IgM Rapid Test is a diagnostic tool used to detect antibodies against the dengue virus in blood samples
Campaign launched to spread awareness regarding dengue prevention and control
Minister was briefed on the nationwide dengue situation
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
If approved, TAK-003 has the potential to become an important dengue prevention option for healthcare providers
Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age
Subscribe To Our Newsletter & Stay Updated